Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study.

Ziemann M, Altermann W, Angert K, Arns W, Bachmann A, Bakchoul T, Banas B, von Borstel A, Budde K, Ditt V, Einecke G, Eisenberger U, Feldkamp T, Görg S, Guthoff M, Habicht A, Hallensleben M, Heinemann FM, Hessler N, Hugo C, Kaufmann M, Kauke T, Koch M, König IR, Kurschat C, Lehmann C, Marget M, Mühlfeld A, Nitschke M, Pego da Silva L, Quick C, Rahmel A, Rath T, Reinke P, Renders L, Sommer F, Spriewald B, Staeck O, Stippel D, Süsal C, Thiele B, Zecher D, Lachmann N.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1056-1066. doi: 10.2215/CJN.13401118. Epub 2019 Jun 18.

PMID:
31213508
2.

Local dynamics in supramolecular polymer networks probed by magnetic particle nanorheology.

Hess M, Roeben E, Habicht A, Seiffert S, Schmidt AM.

Soft Matter. 2019 Jan 30;15(5):842-850. doi: 10.1039/c8sm01802b.

PMID:
30608500
3.

Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange.

Sagmeister MS, Weiss M, Eichhorn P, Habicht A, Habersetzer R, Fischereder M, Schönermarck U.

BMC Nephrol. 2018 Oct 19;19(1):270. doi: 10.1186/s12882-018-1086-z.

4.

Surgical complications and cardiovascular comorbidity - Substantial non-immunological confounders of survival after living donor kidney transplantation.

Khandoga A, Thomas M, Kleespies A, Kühnke L, Andrassy J, Habicht A, Stangl M, Guba M, Angele M, Werner J, Rentsch M.

Surgeon. 2019 Apr;17(2):63-72. doi: 10.1016/j.surge.2018.04.005. Epub 2018 May 31.

PMID:
29861143
5.

Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months.

Wolf S, Hoffmann VS, Habicht A, Kauke T, Bucher J, Schoenberg M, Werner J, Guba M, Andrassy J.

PLoS One. 2018 Apr 16;13(4):e0194975. doi: 10.1371/journal.pone.0194975. eCollection 2018. Review.

6.

Vascular rejection in renal transplant: Diagnostic value of contrast-enhanced ultrasound (CEUS) compared to biopsy.

Mueller-Peltzer K, Negrão de Figueiredo G, Fischereder M, Habicht A, Rübenthaler J, Clevert DA.

Clin Hemorheol Microcirc. 2018;69(1-2):77-82. doi: 10.3233/CH-189115.

PMID:
29630540
7.

Contrast-enhanced ultrasound (CEUS) as a new technique to characterize suspected renal transplant malignancies in renal transplant patients in comparison to standard imaging modalities.

Mueller-Peltzer K, Negrão de Figueiredo G, Fischereder M, Habicht A, Rübenthaler J, Clevert DA.

Clin Hemorheol Microcirc. 2018;69(1-2):69-75. doi: 10.3233/CH-189114.

PMID:
29630539
8.

Renal volume assessed by magnetic resonance imaging volumetry correlates with renal function in living kidney donors pre- and postdonation: a retrospective cohort study.

Lange D, Helck A, Rominger A, Crispin A, Meiser B, Werner J, Fischereder M, Stangl M, Habicht A.

Transpl Int. 2018 Jul;31(7):773-780. doi: 10.1111/tri.13150. Epub 2018 Apr 15.

9.

Dynamic CTA in Native Kidneys Using a Multiphase CT Protocol-Potential of Significant Reduction of Contrast Medium.

Braunagel M, Ortner F, Schönermarck U, Habicht A, Schindler A, Stangl M, Strobl FF, Reiser M, Clevert DA, Trumm C, Helck A.

Acad Radiol. 2018 Jul;25(7):842-849. doi: 10.1016/j.acra.2017.11.012. Epub 2018 Mar 12.

PMID:
29545025
10.

Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.

Banas B, Steubl D, Renders L, Chittka D, Banas MC, Wekerle T, Koch M, Witzke O, Mühlfeld A, Sommerer C, Habicht A, Hugo C, Hünig T, Lindemann M, Schmidt T, Rascle A, Barabas S, Deml L, Wagner R, Krämer BK, Krüger B.

Transpl Int. 2018 Apr;31(4):436-450. doi: 10.1111/tri.13110. Epub 2018 Jan 16.

11.

The diagnostic value of contrast-enhanced ultrasound (CEUS) as a new technique for imaging of vascular complications in renal transplants compared to standard imaging modalities.

Mueller-Peltzer K, Rübenthaler J, Fischereder M, Habicht A, Reiser M, Clevert DA.

Clin Hemorheol Microcirc. 2017;67(3-4):407-413. doi: 10.3233/CH-179221.

PMID:
28885208
12.

Antibody response to HBV vaccination on dialysis does not correlate with the development of deNovo anti-HLA antibodies after renal transplantation.

Kauke T, Link M, Rentsch M, Stangl M, Guba M, Andrassy J, Werner J, Meiser B, Fischereder M, Habicht A.

Transpl Immunol. 2017 Jun;42:5-8. doi: 10.1016/j.trim.2017.04.003. Epub 2017 Apr 28.

PMID:
28457920
13.

Sodium storage in human tissues is mediated by glycosaminoglycan expression.

Fischereder M, Michalke B, Schmöckel E, Habicht A, Kunisch R, Pavelic I, Szabados B, Schönermarck U, Nelson PJ, Stangl M.

Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F319-F325. doi: 10.1152/ajprenal.00703.2016. Epub 2017 Apr 26.

14.

Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantation.

Ziemann M, Heßler N, König IR, Lachmann N, Dick A, Ditt V, Budde K, Reinke P, Eisenberger U, Suwelack B, Klein T, Westhoff TH, Arns W, Ivens K, Habicht A, Renders L, Stippel D, Bös D, Sommer F, Görg S, Nitschke M, Feldkamp T, Heinemann FM, Kelsch R.

Nephrol Dial Transplant. 2017 May 1;32(5):880-889. doi: 10.1093/ndt/gfw462.

PMID:
28340245
15.

Effects of Dopamine Donor Pretreatment on Graft Survival after Kidney Transplantation: A Randomized Trial.

Schnuelle P, Schmitt WH, Weiss C, Habicht A, Renders L, Zeier M, Drüschler F, Heller K, Pisarski P, Banas B, Krämer BK, Jung M, Lopau K, Olbricht CJ, Weihprecht H, Schenker P, De Fijter JW, Yard BA, Benck U.

Clin J Am Soc Nephrol. 2017 Mar 7;12(3):493-501. doi: 10.2215/CJN.07600716. Epub 2017 Feb 17.

16.

A randomized, double-blind, placebo-controlled, dose-escalation first-in-man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, AVX001, in patients with mild to moderate plaque psoriasis.

Omland SH, Habicht A, Damsbo P, Wilms J, Johansen B, Gniadecki R.

J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1161-1167. doi: 10.1111/jdv.14128. Epub 2017 Feb 17.

PMID:
28107559
17.

De novo donor-specific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability.

Kauke T, Oberhauser C, Lin V, Coenen M, Fischereder M, Dick A, Schoenermarck U, Guba M, Andrassy J, Werner J, Meiser B, Angele M, Stangl M, Habicht A.

Transpl Int. 2017 Apr;30(4):360-370. doi: 10.1111/tri.12887. Epub 2017 Feb 16.

18.

[Care of the adult kidney transplant recipient].

Habicht A, Stangl M.

MMW Fortschr Med. 2016 Nov;158(20):64-72. doi: 10.1007/s15006-016-9013-3. Review. German. No abstract available.

PMID:
27844359
19.

Real-life efficacy of pregabalin for the treatment of peripheral neuropathic pain in daily clinical practice in Denmark: the NEP-TUNE study.

Crawford ME, Poulsen PB, Schiøttz-Christensen B, Habicht A, Strand M, Bach FW.

J Pain Res. 2016 May 20;9:293-302. doi: 10.2147/JPR.S102744. eCollection 2016.

20.

Dynamic Contrast-Enhanced Computed Tomography: A New Diagnostic Tool to Assess Renal Perfusion After Ischemia-Reperfusion Injury in Mice: Correlation of Perfusion Deficit to Histopathologic Damage.

Braunagel M, Helck A, Wagner A, Schupp N, Bröcker V, Reiser M, Notohamiprodjo M, Meiser B, Habicht A.

Invest Radiol. 2016 May;51(5):316-22. doi: 10.1097/RLI.0000000000000245.

PMID:
26741893
21.

Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.

Kauke T, Klimaschewski S, Schoenermarck U, Fischereder M, Dick A, Guba M, Stangl M, Werner J, Meiser B, Habicht A.

PLoS One. 2016 Jan 5;11(1):e0146075. doi: 10.1371/journal.pone.0146075. eCollection 2016.

22.

Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.

Schnitzler F, Friedrich M, Stallhofer J, Schönermarck U, Fischereder M, Habicht A, Karbalai N, Wolf C, Angelberger M, Olszak T, Beigel F, Tillack C, Göke B, Zachoval R, Denk G, Guba M, Rust C, Grüner N, Brand S.

PLoS One. 2015 Aug 19;10(8):e0135807. doi: 10.1371/journal.pone.0135807. eCollection 2015.

23.

SDF-1/CXCR4/CXCR7 is pivotal for vascular smooth muscle cell proliferation and chronic allograft vasculopathy.

Thomas MN, Kalnins A, Andrassy M, Wagner A, Klussmann S, Rentsch M, Habicht A, Pratschke S, Stangl M, Bazhin AV, Meiser B, Fischereder M, Werner J, Guba M, Andrassy J.

Transpl Int. 2015 Dec;28(12):1426-35. doi: 10.1111/tri.12651. Epub 2015 Sep 1.

24.

Determination of split renal function using dynamic CT-angiography: preliminary results.

Helck A, Schönermarck U, Habicht A, Notohamiprodjo M, Stangl M, Klotz E, Nikolaou K, la Fougère C, Clevert DA, Reiser M, Becker C.

PLoS One. 2014 Mar 11;9(3):e91774. doi: 10.1371/journal.pone.0091774. eCollection 2014.

25.

Beyond C4d: the ultrastructural appearances of endothelium in ABO-incompatible renal allografts.

Bröcker V, Pfaffenbach A, Habicht A, Chatzikyrkou C, Kreipe HH, Haller H, Scheffner I, Gwinner W, Zilian E, Immenschuh S, Schwarz A, Horn PA, Heinemann FM, Becker JU.

Nephrol Dial Transplant. 2013 Dec;28(12):3101-9. doi: 10.1093/ndt/gft373. Epub 2013 Sep 29.

PMID:
24081856
26.

Headaches after renal transplantation--a case report.

Rau S, von Baumgarten L, Habicht A, Fischereder M, Schönermarck U.

Transplant Proc. 2013 Sep;45(7):2795-7. doi: 10.1016/j.transproceed.2013.03.051.

PMID:
24034052
27.

Neutrophil gelatinase-associated lipocalin and end-stage renal disease: it is not all about the kidneys!

Rau S, Habicht A, Kauke T, Hillmer A, Wessely M, Stangl M, Guba M, Fischereder M, Schönermarck U.

Eur J Clin Invest. 2013 Aug;43(8):816-20. doi: 10.1111/eci.12110. Epub 2013 May 25.

PMID:
23710757
28.

CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival.

D'Addio F, Ueno T, Clarkson M, Zhu B, Vergani A, Freeman GJ, Sayegh MH, Ansari MJ, Fiorina P, Habicht A.

PLoS One. 2013 Apr 4;8(4):e60391. doi: 10.1371/journal.pone.0060391. Print 2013.

29.

Impact of hourly emergency department patient volume on blood culture contamination and diagnostic yield.

Halverson S, Malani PN, Newton DW, Habicht A, Vander Have K, Younger JG.

J Clin Microbiol. 2013 Jun;51(6):1721-6. doi: 10.1128/JCM.03422-12. Epub 2013 Mar 20.

30.

BK virus-associated nephropathy: neutrophil gelatinase-associated lipocalin as a new diagnostic tool?

Rau S, Schönermarck U, Jäger G, Stangl M, Guba M, Meiser B, Fischereder M, Habicht A.

Clin Transplant. 2013 Mar-Apr;27(2):E184-91. doi: 10.1111/ctr.12081. Epub 2013 Feb 13.

PMID:
23406465
31.

Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysis.

Andrassy J, Hoffmann VS, Rentsch M, Stangl M, Habicht A, Meiser B, Fischereder M, Jauch KW, Guba M.

Transplantation. 2012 Dec 27;94(12):1208-17. doi: 10.1097/TP.0b013e3182708e56. Review.

PMID:
23269449
32.

Calcineurin inhibitor dose-finding before kidney transplantation in HIV patients.

Pulzer A, Seybold U, Schönermarck U, Stangl M, Habicht A, Bogner JR, Franke J, Fischereder M.

Transpl Int. 2013 Mar;26(3):254-8. doi: 10.1111/tri.12020. Epub 2012 Dec 10.

33.

Decompression of inflammatory edema along with endothelial cell therapy expedites regeneration after renal ischemia-reperfusion injury.

Herrler T, Wang H, Tischer A, Schupp N, Lehner S, Meyer A, Wallmichrath J, Habicht A, Mfarrej B, Anders HJ, Bartenstein P, Jauch KW, Hacker M, Guba M.

Cell Transplant. 2013;22(11):2091-103. doi: 10.3727/096368912X658700. Epub 2012 Oct 31.

PMID:
23128032
34.

Effect of Apheresis for ABO and HLA Desensitization on Anti-Measles Antibody Titers in Renal Transplantation.

Schönermarck U, Kauke T, Jäger G, Habicht A, Wendler T, Andrassy J, Guba M, Stangl M, Fischereder M.

J Transplant. 2011;2011:869065. doi: 10.1155/2011/869065. Epub 2011 Dec 8.

35.

Does participation in clinical trials influence the costs of future management of patients?

Hvenegaard A, Juhl HH, Habicht A.

Eur J Health Econ. 2012 Oct;13(5):569-74. doi: 10.1007/s10198-011-0359-2. Epub 2011 Nov 10.

PMID:
22072320
36.

Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience.

Habicht A, Bröker V, Blume C, Lorenzen J, Schiffer M, Richter N, Klempnauer J, Haller H, Lehner F, Schwarz A.

Nephrol Dial Transplant. 2011 Dec;26(12):4124-31. doi: 10.1093/ndt/gfr215. Epub 2011 May 28.

PMID:
21622990
37.

The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury.

Rong S, Park JK, Kirsch T, Yagita H, Akiba H, Boenisch O, Haller H, Najafian N, Habicht A.

J Am Soc Nephrol. 2011 Mar;22(3):484-95. doi: 10.1681/ASN.2010030321. Epub 2011 Feb 25.

38.

A novel clinically relevant approach to tip the balance toward regulation in stringent transplant model.

D'Addio F, Yuan X, Habicht A, Williams J, Ruzek M, Iacomini J, Turka LA, Sayegh MH, Najafian N, Ansari MJ.

Transplantation. 2010 Aug 15;90(3):260-9.

39.

Prolonged graft survival in older recipient mice is determined by impaired effector T-cell but intact regulatory T-cell responses.

Denecke C, Bedi DS, Ge X, Kim IK, Jurisch A, Weiland A, Habicht A, Li XC, Tullius SG.

PLoS One. 2010 Feb 16;5(2):e9232. doi: 10.1371/journal.pone.0009232.

40.

A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy.

Yuan X, Paez-Cortez J, Schmitt-Knosalla I, D'Addio F, Mfarrej B, Donnarumma M, Habicht A, Clarkson MR, Iacomini J, Glimcher LH, Sayegh MH, Ansari MJ.

J Exp Med. 2008 Dec 22;205(13):3133-44. doi: 10.1084/jem.20081937. Epub 2008 Dec 1.

41.

The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model.

Ueno T, Habicht A, Clarkson MR, Albin MJ, Yamaura K, Boenisch O, Popoola J, Wang Y, Yagita H, Akiba H, Ansari MJ, Yang J, Turka LA, Rothstein DM, Padera RF, Najafian N, Sayegh MH.

J Clin Invest. 2008 Feb;118(2):742-51. doi: 10.1172/JCI32451.

42.

Pre-transplant predictors of cerebrovascular events after kidney transplantation.

Aull-Watschinger S, Konstantin H, Demetriou D, Schillinger M, Habicht A, Hörl WH, Watschinger B.

Nephrol Dial Transplant. 2008 Apr;23(4):1429-35. Epub 2007 Nov 28.

PMID:
18045824
43.

Striking dichotomy of PD-L1 and PD-L2 pathways in regulating alloreactive CD4(+) and CD8(+) T cells in vivo.

Habicht A, Kewalaramani R, Vu MD, Demirci G, Blazar BR, Sayegh MH, Li XC.

Am J Transplant. 2007 Dec;7(12):2683-92. Epub 2007 Oct 9.

44.

A link between PDL1 and T regulatory cells in fetomaternal tolerance.

Habicht A, Dada S, Jurewicz M, Fife BT, Yagita H, Azuma M, Sayegh MH, Guleria I.

J Immunol. 2007 Oct 15;179(8):5211-9.

45.

PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection.

Tanaka K, Albin MJ, Yuan X, Yamaura K, Habicht A, Murayama T, Grimm M, Waaga AM, Ueno T, Padera RF, Yagita H, Azuma M, Shin T, Blazar BR, Rothstein DM, Sayegh MH, Najafian N.

J Immunol. 2007 Oct 15;179(8):5204-10.

46.

New insights in CD28-independent allograft rejection.

Habicht A, Najafian N, Yagita H, Sayegh MH, Clarkson MR.

Am J Transplant. 2007 Aug;7(8):1917-26.

47.

A novel alloantigen-specific CD8+PD1+ regulatory T cell induced by ICOS-B7h blockade in vivo.

Izawa A, Yamaura K, Albin MJ, Jurewicz M, Tanaka K, Clarkson MR, Ueno T, Habicht A, Freeman GJ, Yagita H, Abdi R, Pearson T, Greiner DL, Sayegh MH, Najafian N.

J Immunol. 2007 Jul 15;179(2):786-96.

48.

T cell costimulatory pathways in allograft rejection and tolerance: what's new?

Habicht A, Sayegh MH.

Curr Opin Organ Transplant. 2007 Feb;12(1):17-22.

PMID:
27792084
49.

Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial.

Demetriou D, Habicht A, Schillinger M, Hörl WH, Vychytil A.

Kidney Int. 2006 Nov;70(9):1649-55. Epub 2006 Sep 6.

50.

Specificity of CD4+CD25+ regulatory T cell function in alloimmunity.

Sánchez-Fueyo A, Sandner S, Habicht A, Mariat C, Kenny J, Degauque N, Zheng XX, Strom TB, Turka LA, Sayegh MH.

J Immunol. 2006 Jan 1;176(1):329-34.

Supplemental Content

Loading ...
Support Center